Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$550.72 USD

550.72
463,800

+3.25 (0.59%)

Updated Aug 27, 2024 04:00 PM ET

After-Market: $551.01 +0.29 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Nevro Bolsters Growth Prospects With New Manufacturing Plan

Nevro (NVRO) commences plan for manufacturing operations in Costa Rica, thereby expanding its geographic footprint and boosting growth prospects.

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

McKesson (MCK) Down 4.3% Since Last Earnings Report: Can It Rebound?

McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

McKesson Extends Partnership With CDC to Fight Coronavirus

McKesson (MCK) extends partnership with the CDC to aid in the distribution of future COVID-19 vaccines.

Company News for Aug 4, 2020

Companies In The News Are: TSN, MCK, MCY, TKR.

McKesson (MCK) Q1 Earnings and Revenues Surpass Estimates

McKesson's (MCK) fiscal first-quarter 2021 results benefit from strong U.S. Pharmaceutical and Specialty Solutions segment.

McKesson (MCK) Beats Q1 Earnings and Revenue Estimates

McKesson (MCK) delivered earnings and revenue surprises of 17.87% and 3.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

McKesson (MCK) to Post Q1 Earnings: What's in the Offing?

McKesson's (MCK) fiscal first-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.

Earnings Preview: McKesson (MCK) Q1 Earnings Expected to Decline

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

Trina Mukherjee headshot

Near-Term Outlook Bleak for Medical Dental Supplies Industry

Digital influence coupled with AI & Robotics can drive the medical dental supplies industry amid the coronavirus-induced crisis.

McKesson (MCK) Up 5.2% Since Last Earnings Report: Can It Continue?

McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

McKesson (MCK) Q4 Earnings and Revenues Surpass Estimates

McKesson's (MCK) fiscal fourth-quarter 2020 results benefit from strong segmental performance.

McKesson (MCK) Surpasses Q4 Earnings and Revenue Estimates

McKesson (MCK) delivered earnings and revenue surprises of 4.15% and 5.62%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

McKesson (MCK) to Report Q4 Earnings: What's in the Cards?

McKesson's (MCK) fiscal fourth-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions and Medical-Surgical Solutions segments.

McKesson (MCK) Earnings Expected to Grow: Should You Buy?

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sriparna Ghosal headshot

3 MedTech Stocks Likely to Have Braved Coronavirus Blow in Q1

Despite the widespread coronavirus crisis, there are a few MedTech companies which are expected to have gained in the first quarter.

ResMed (RMD) Grows on Stellar Mask Sales, SaaS Capabilities

Within SaaS, ResMed (RMD) shows strong momentum in the Brightree service portfolio.

Here's Why You Should Hold on to Luminex (LMNX) Stock Now

Luminex (LMNX) continues to benefit from robust product portfolio, solid molecular diagnostics and ARIES platforms.

BD (BDX) Receives EUA for New Coronavirus Detection Test

Becton, Dickinson (BDX) receives EUA from the FDA for another molecular diagnostic test for COVID-19, which can return results in two to three hours.

Here's Why You Should Invest in Cooper Companies (COO) Stock

Cooper Companies (COO) continues to gain traction from its robustly performing CVI and CSI businesses.

Masimo SafetyNet to Help Clinicians Fight Coronavirus Better

Masimo (MASI) announces the full market release of Masimo SafetyNet, which is a remote patient management solution that will help in the fight against the COVID-19 pandemic.

Should Value Investors Buy McKesson (MCK) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.

Here's Why You Should Hold on to Avanos Medical Stock Now

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.